Friday, April 17, 2020 Daily Archives

COVID-19 pipeline: Industry flexing its Abs in fight against coronavirus

by

From Regeneron to GSK, monoclonal to bispecific, industry is increasingly looking at antibody (Ab) therapies to tackle the novel coronavirus. We bring you a comprehensive guide to what’s in the pipeline. Only six weeks ago, Bioprocess Insider brought to you a highlights reel of the treatments and prophylaxis in the development pipeline to treat COVID-19, caused by the novel coronavirus (SARS-CoV-2). But six weeks is a very long time in a global pandemic, and since then new projects have begun…

April 17, 2020

Over-capacity concern drives Bellicum to sell Texas CAR-T plant for $15m

by

The University of Texas MD Anderson Cancer Center has acquired the 60,000 square-foot Houston facility and entered into an agreement to manufacture cellular therapies for Bellicum Pharmaceuticals. The $15 million (€13.8 million) sale, first announced in January, went through this week and sees MD Anderson Cancer Center take over operations at the Houston, Texas site less than a year after Bellicum completed the buildout of the manufacturing space. The sale took place following an evaluation of Bellicum’s manufacturing strategy as…

April 17, 2020